Nasus Pharma Ltd.盘中异动大幅拉升7.14%_老虎社区_美港股上老虎

Nasus Pharma Ltd.盘中异动大幅拉升7.14%

市场透视2025-11-22

北京时间2025年11月22日01时57分，Nasus Pharma Ltd.（NSRX.us）股票出现异动，股价快速上涨7.14%。截至发稿，该股报7.50美元/股，成交量165股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-419269.43美元，每股收益-0.05美元，毛利0.00美元，市盈率-44.35倍。机构评级方面，在所有1家参与评级的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2585171598?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-22 01:57","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2585171598","market":"us","top_or_hot":-1,"title":"Nasus Pharma Ltd.盘中异动 大幅拉升7.14%","media":"市场透视","content":"<div>\n<p>北京时间2025年11月22日01时57分，Nasus Pharma Ltd.（NSRX.us）股票出现异动，股价快速上涨7.14%。截至发稿，该股报7.50美元/股，成交量165股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-419269.43美元，每股收益-0.05美元，毛利0.00美元，市盈率-44.35倍。机构评级方面，在所有1家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015702a4b21ff7&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasus Pharma Ltd.盘中异动 大幅拉升7.14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasus Pharma Ltd.盘中异动 大幅拉升7.14%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-22 01:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015702a4b21ff7&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年11月22日01时57分，Nasus Pharma Ltd.（NSRX.us）股票出现异动，股价快速上涨7.14%。截至发稿，该股报7.50美元/股，成交量165股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-419269.43美元，每股收益-0.05美元，毛利0.00美元，市盈率-44.35倍。机构评级方面，在所有1家参与评级的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015702a4b21ff7&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NSRX","symbol_name":"Nasus Pharma Ltd.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015702a4b21ff7&s=b","article_id":"2585171598","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122015702a4b21ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2585171598","pubTimestamp":1763747821,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年11月22日01时57分，Nasus Pharma Ltd.股票出现异动，股价快速上涨7.14%。Nasus Pharma Ltd.股票所在的制药行业中，整体涨幅为1.56%。其相关个股中，Alvotech C/Wts 、Sunshine Biopharma Inc C/Wts 、Scilex Holding Company涨幅较大，Shuttle Pharmaceuticals Holdings, Inc.、Inmed Pharmaceuticals Inc.、Akanda Corp.较为活跃，换手率分别为230.65%、9.95%、8.03%，振幅较大的相关个股有Alvotech C/Wts 、Shuttle Pharmaceuticals Holdings, Inc.、Caring Brands, Inc.，振幅分别为38.81%、27.92%、19.67%。Nasus Pharma Ltd.公司简介：Nasus Pharma Ltd是一家临床阶段的专业制药公司，主要专注于开发用于治疗紧急医疗状况的鼻内药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"NSRX":"Nasus Pharma Ltd.","BK4007":"制药"},"translate_title":"Nasus Pharma Ltd. rose sharply by 7.14% during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NSRX":1.5},"content_text":"北京时间2025年11月22日01时57分，Nasus Pharma Ltd.（NSRX.us）股票出现异动，股价快速上涨7.14%。截至发稿，该股报7.50美元/股，成交量165股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-419269.43美元，每股收益-0.05美元，毛利0.00美元，市盈率-44.35倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Nasus Pharma Ltd.股票所在的制药行业中，整体涨幅为1.56%。其相关个股中，Alvotech C/Wts (To Pur Com)、Sunshine Biopharma Inc C/Wts (To Pur Com)、Scilex Holding Company涨幅较大，Shuttle Pharmaceuticals Holdings, Inc.、Inmed Pharmaceuticals Inc.、Akanda Corp.较为活跃，换手率分别为230.65%、9.95%、8.03%，振幅较大的相关个股有Alvotech C/Wts (To Pur Com)、Shuttle Pharmaceuticals Holdings, Inc.、Caring Brands, Inc.，振幅分别为38.81%、27.92%、19.67%。Nasus Pharma Ltd.公司简介：Nasus Pharma Ltd是一家临床阶段的专业制药公司，主要专注于开发用于治疗紧急医疗状况的鼻内药物。该公司正在开发一些基于其微球技术的鼻内粉末产品，旨在帮助患者应对阿片类药物过量和过敏性休克等几种急性紧急情况。其产品组合包括许多项目：鼻内纳洛酮完成关键研究和鼻内肾上腺素（2期）以及一些临床前POC项目。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}